We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen Broadens Oncology Reach With $1.9 Billion Five Prime Therapeutics Purchase
Amgen Broadens Oncology Reach With $1.9 Billion Five Prime Therapeutics Purchase
Amgen has agreed to acquire Five Prime Therapeutics, a South San Francisco biotech company, for $1.9 billion, a deal that will net the biopharma titan a pipeline that includes a promising investigational gastric cancer drug.